| Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis C Liu, T Feng, N Zhu, P Liu, X Han, M Chen, X Wang, N Li, Y Li, Y Xu, S Si Scientific reports 5 (1), 9530, 2015 | 79 | 2015 |
| Rutaecarpine suppresses atherosclerosis in ApoE−/− mice through upregulating ABCA1 and SR-BI within RCT [S] Y Xu, Q Liu, Y Xu, C Liu, X Wang, X He, N Zhu, J Liu, Y Wu, Y Li, N Li, ... Journal of Lipid Research 55 (8), 1634-1647, 2014 | 63 | 2014 |
| The antituberculosis antibiotic capreomycin inhibits protein synthesis by disrupting interaction between ribosomal proteins L12 and L10 Y Lin, Y Li, N Zhu, Y Han, W Jiang, Y Wang, S Si, J Jiang Antimicrobial agents and chemotherapy 58 (4), 2038-2044, 2014 | 51 | 2014 |
| Discovery of the disubstituted oxazole analogues as a novel class anti-tuberculotic agents against MDR-and XDR-MTB D Li, N Gao, N Zhu, Y Lin, Y Li, M Chen, X You, Y Lu, K Wan, JD Jiang, ... Bioorganic & Medicinal Chemistry Letters 25 (22), 5178-5181, 2015 | 38 | 2015 |
| Identification of a compound that inhibits the growth of Gram-Negative bacteria by blocking BamA–BamD interaction Y Li, X Zhu, J Zhang, Y Lin, X You, M Chen, Y Wang, N Zhu, S Si Frontiers in Microbiology 11, 1252, 2020 | 32 | 2020 |
| Identification of a novel liver X receptor agonist that regulates the expression of key cholesterol homeostasis genes with distinct pharmacological characteristics N Li, X Wang, Y Xu, Y Lin, N Zhu, P Liu, D Lu, S Si Molecular pharmacology 91 (4), 264-276, 2017 | 31 | 2017 |
| Identification of an anti-TB compound targeting the tyrosyl-tRNA synthetase N Zhu, Y Lin, D Li, N Gao, C Liu, X You, J Jiang, W Jiang, S Si Journal of Antimicrobial Chemotherapy 70 (8), 2287-2294, 2015 | 31 | 2015 |
| Identification of anti-tuberculosis agents that target the cell-division protein FtsZ Y Lin, N Zhu, Y Han, J Jiang, S Si The Journal of antibiotics 67 (9), 671-676, 2014 | 31 | 2014 |
| SIRT1 activator E1231 protects from experimental atherosclerosis and lowers plasma cholesterol and triglycerides by enhancing ABCA1 expression T Feng, P Liu, X Wang, J Luo, X Zuo, X Jiang, C Liu, Y Li, N Li, M Chen, ... Atherosclerosis 274, 172-181, 2018 | 24 | 2018 |
| IMB-T130 targets 3-dehydroquinate synthase and inhibits Mycobacterium tuberculosis N Zhu, X Wang, D Li, Y Lin, X You, J Jiang, Y Xu, W Jiang, S Si Scientific Reports 8 (1), 17439, 2018 | 16 | 2018 |
| Identification of TB-E12 as a novel FtsZ inhibitor with anti-tuberculosis activity Y Lin, H Zhang, N Zhu, X Wang, Y Han, M Chen, J Jiang, S Si Tuberculosis 110, 79-85, 2018 | 16 | 2018 |
| Targeting E. coli invasion of the blood–brain barrier for investigating the pathogenesis and therapeutic development of E. coli meningitis N Zhu, W Liu, A Prakash, C Zhang, KS Kim Cellular microbiology 22 (10), e13231, 2020 | 15 | 2020 |
| A novel SIRT1 activator E6155 improves insulin sensitivity in type 2 diabetic KKAy mice P Liu, T Feng, X Zuo, X Wang, J Luo, N Li, X Han, N Zhu, S Xu, Y Xu, ... Biochemical and biophysical research communications 498 (3), 633-639, 2018 | 13 | 2018 |
| Virtual screening for the identification of novel inhibitors of Mycobacterium tuberculosis cell wall synthesis: inhibitors targeting RmlB and RmlC JX Ren, HL Qian, YX Huang, NY Zhu, SY Si, Y Xie Computers in Biology and Medicine 58, 110-117, 2015 | 13 | 2015 |
| Therapeutic development of group B Streptococcus meningitis by targeting a host cell signaling network involving EGFR N Zhu, C Zhang, A Prakash, Z Hou, W Liu, W She, A Morris, K Sik Kim EMBO Molecular Medicine 13 (3), e12651, 2021 | 9 | 2021 |
| Identification of anti-Gram-negative bacteria agents targeting the interaction between ribosomal proteins L12 and L10 W Wang, C Liu, N Zhu, Y Lin, J Jiang, Y Wang, Y Li, S Si Acta Pharmaceutica Sinica B 8 (5), 772-783, 2018 | 6 | 2018 |
| Bacteria reduce flagellin synthesis to evade microglia-astrocyte-driven immunity in the brain H Sun, X Wan, Y Fan, P Liu, Y Song, N Zhu, Z Duan, Q Wang, F Chen, ... Cell Reports 40 (1), 2022 | 5 | 2022 |
| Corrigendum: Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis C Liu, T Feng, N Zhu, P Liu, X Han, M Chen, X Wang, N Li, Y Li, Y Xu, S Si Scientific reports 5, 2015 | 4 | 2015 |
| Identification of novel anti-tuberculosis lead compound targeting shikimate kinase X WANG, N ZHU, W JIANG, S SI Acta Pharmaceutica Sinica, 878-886, 2018 | 1 | 2018 |
| E1231, an activator of SIRT1, regulates cholesterol and lipid metabolism through SIRT1-LXRALPHA-ABCA1 pathway S Si, T Feng, P Liu, X Wang, C Liu, N Li, N Zhu, M Chen, Y Li, X Han, ... Atherosclerosis 263, e75, 2017 | | 2017 |
